HDL: Bridging past and present with a look at the future

FASEB Journal

Volumn 22, Issue 12, 2008, Pages 4044-4054

  Scanu, Angelo M ^a   Edelstein, Celina ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

ApoA I; ApoA II; ATP binding cassette transporter; Lecithin cholesterol acyl transferase; Paraoxonase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ARYLDIALKYLPHOSPHATASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; CHOLESTEROL TRANSPORT; HEART PROTECTION; HUMAN; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ATHEROSCLEROSIS; GLYCOSPHINGOLIPIDS; HUMANS; LIPOPROTEINS, HDL; PHOSPHOLIPIDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SOLUTIONS;

EID: 57349114776     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-117150     Document Type: Review

References (99)

1. Gofman, J. W., Lindgren, F. T., and Elliott, H. (1949) Ultracentrifugal studies of lipoproteins of human serum. J. Biol. Chem. 179, 973-979
2. Scanu, A., and Schiano, N. (1954) Method of continuous ether extraction of lipids applied to the study of serum lipoproteins. I. Normal human sera. Riv. Ist. Sieroter. Ital. 29, 276
3. Scanu, A., Lewis, L. A., and Bumpus, F. M. (1958) Separation and characterization of the protein moiety of human alpha-lipoprotein. Arch. Biochem. Biophys. 74, 390-397
4. 3. Proc. Natl. Acad. Sci. 54, 1699-1705
5. Scanu, A., and Hirz, R. (1968) On the structure of human serum high-density lipoprotein: studies by the technique of circular dichroism. Proc. Natl. Acad. Sci. 59, 890-894
6. Scanu, A., and Granda, J. L. (1968) Comparative optical properties of human serum low- and high-density lipoproteins before and after delipidation. Progr. Biochem. Pharmacol. 4, 153
7. Scanu, A., and Hughes, W. L. (1960) Recombining capacity toward lipids of the protein moiety of human serum α1-lipoprotein. J. Biol. Chem. 235, 2876-2883
8. Scanu, A. M., and Wisdom, C. (1972) Serum lipoproteins structure and function. Annu. Rev. Biochem. 41, 703-730
9. Scanu, A., Cump, E., Toth, J., Koga, S., Stiller, E., and Albers, L. (1970) Degradation and reassembly of a human serum high-density lipoprotein. Evidence for differences in lipid affinity among three classes of polypeptide chains. Biochemistry 9, 1327-1335
10. Lagocki, P. A., and Scanu, A. M. (1980) In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. J. Biol. Chem. 255, 3701-3706
11. Edelstein, C., Halari, M., and Scanu, A. M. (1982) On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. J. Biol. Chem. 257, 7189-7195
12. Scanu, A. M., Edelstein, C., and Gordon, J. I. (1984) Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance. Clin. Physiol. Biochem. 2, 111-122
13. Brewer, H. B., Fairwell, T., LaRue, A., Ronan, R., Houser, A., and Bronzert, T. J. (1978) The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem. Biophys. Res. Commun. 80, 623-630
14. Shoulders, C. C., Kornblihtt, A. R., Munro, B. S., and Baralle, F. E. (1983) Gene structure of human apolipoprotein Al. Nucleic Acids Res. 11, 2827-2837
15. Segrest, J. P., Jones, M. K., De Loof, H., Brouillette, C. G., Venkatachalapathi, Y. V., and Anantharamaiah, G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33, 141-166
16. Shen, B. W., and Scanu, A. M. (1980) Properties of human apolipoprotein A-I at the air-water interface. Biochemistry 19, 3643-3650
17. Shen, B. W. (1985) Lipid-protein interaction at solid-water interface. Adsorption of human apo-high density lipoprotein to amphiphilic interfaces. J. Biol. Chem. 260, 1032-1039
18. Krebs, K. E., Ibdah, J. A., and Phillips, M. C. (1988) A comparison of the surface activities of human apolipoproteins A-I and A-II at the air/water interface. Biochim. Biophys. Acta 959, 229-237
19. Ibdah, J. A., Krebs, K. E., and Phillips, M. C. (1989) The surface properties of apolipoproteins A-I and A-II at the lipid/water interface. Biochim. Biophys. Acta 1004, 300-308
20. Brouillette, C. G., Anantharamaiah, G. M., Engler, J. A., and Borhani, D. W. (2001) Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta 1531, 4-46
21. Saito, H., Lund-Katz, S., and Phillips, M. C. (2004) Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Progr. Lipid. Res. 43, 350-380
22. Edelstein, C., and Scanu, A. M. (1980) Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipoprotein A-I in solution. J. Biol. Chem. 255, 5747-5754
23. Vitello, L. B., and Scanu, A. M. (1976) Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions. J. Biol. Chem. 251, 1131-1136
24. Ajees, A. A., Anantharamaiah, G. M., Mishra, V. K., Hussain, M. M., and Murthy, H. M. K. (2006) Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. 103, 2126-2131
25. Jonas, A. (1986) Reconstitution of high density lipoproteins. Methods Enzymol. 128, 553-567
26. Davidson, W. S., and Thompson, T. B. (2007) The structure of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 282, 22249-22253
27. Segrest, J. P., Jones, M. K., Klon, A. E., Sheldahl, C. J., Hellinger, M., De Loof, H., and Harvey, S. C. (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274, 31755-31758
28. Koppaka, V., Silvestro, L., Engler, J. A., Brouillette, C. G., and Axelsen, P. H. (1999) The structure of human lipoprotein A-I. Evidence for the "belt" model. J. Biol. Chem. 274, 14541-14544
29. Li, Y., Kijac, A. Z., Sligar, S. G., and Rienstra, C. M. (2006) Structural analysis of nanoscale self-assembled discoidal lipid bilayers by solid-state NMR spectroscopy. Biophys. J. 91, 3819-3828
30. Bhat, S., Sorci-Thomas, M. G., Alexander, E. T., Samuel, M. P., and Thomas, M. J. (2005) Intermolecular contact between globular N-terminal fold and C-terminal domain of apoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry. J. Biol. Chem. 280, 33015-33025
31. Ritter, M. C., and Scanu, A. M. (1977) Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies. J. Biol. Chem. 252, 1208-1216
32. Jonas, A., Kezdy, K. E., Williams, M. I., and Rye, K. A. (1988) Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: effects of plasma protein factors. J. Lipid Res. 29, 1349-1357
33. Sparks, D. L., Davidson, W. S., Lund-Katz, S., and Phillips, M. C. (1995) Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J. Biol. Chem. 270, 26910-26917
34. Li, H. H., Lyles, D. S., Pan, W., Alexander, E., Thomas, M. J., and Sorci-Thomas, M. G. (2002) ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J. Biol. Chem. 277, 39093-39101
35. Jonas, A., Wald, J. H., Toohill, K. L., Krul, E. S., and Kezdy, K. E. (1990) Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123-22129
36. Brewer, H. B., Lux, S. E., Ronan, R., and John, K. M. (1972) Amino acid sequence of human apolp-gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc. Natl. Acad. Sci. 69, 1304-1308
37. Vitello, L. B., and Scanu, A. M. (1976) Studies on human serum high-density lipoproteins. Self-association of human serum apolipoprotein A-II in aqueous solutions. Biochemistry 15, 1161-1165
38. Teng, T. L., Barbeau, D. L., and Scanu, A. M. (1978) Sedimentation behavior of native and reduced apolipoprotein A-II from human high density lipoproteins. Biochemistry 17, 17-21
39. Barbeau, D. L., Teng, T. L., and Scanu, M. (1977) The selfassociation of apolipoprotein A-II from plasma high density lipoproteins of rhesus monkey (Macaca mulatta). J. Biol. Chem. 252, 6745-6749
40. Gursky, O., and Atkinson, D. (1996) High- and low-temperature unfolding of human high-density apolipoprotein A-2. Protein Sci. 5, 1874-1882
41. Kumar, M. S., Carson, M., Hussain, M. M., and Murthy, H. M. K. (2002) Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions. Biochemistry 41, 11681-11691
42. Scanu, A. M., Edelstein, C., and Wolf, R. H. (1974) Chimpanzee (pan troglodytes) serum high density lipoproteins: isolation and properties of their two major apolipoproteins. Biochim. Biophys. Acta 351, 341-347
43. Edelstein, C., Lim, C. T., and Scanu, A. M. (1973) The serum high density lipoproteins of Macacus rhesus. II. Isolation, purification, and characterization of their two major polypeptides. J. Biol. Chem. 248, 7653-7660
44. Scanu, A. M. (1975) Polypeptide A-II of serum high density lipoproteins: a lipophilic protein of phylogenetic interest. PAABS Revista. 4, 1-5
45. Massey, J. B., Gotto, A. M., and Pownall, H. J. (1984) Thermodynamics of lipid-protein association: enthalpy of association of apolipoprotein A-II with dimyristoylphosphatidylcholine-cholesterol mixtures. Biochim. Biophys. Acta 794, 137-141
46. Massey, J. B., Gotto, A. M., Jr., and Pownall, H. J. (1980) Dynamics of lipid-protein interactions. Interaction of apolipoprotein A-II from human plasma high density lipoproteins with dimyristoylphosphatidylcholine. J. Biol. Chem. 255, 10167-10173
47. Silva, R. A. G. D., Schneeweis, L. A., Krishnan, S. C., Zhang, X., Axelsen, P. H., and Davidson, W. S. (2007) The structure of apolipoprotein A-II in discoidal high density lipoproteins. J. Biol. Chem. 282, 9713-9721
48. Ritter, M. C., and Scanu, A. M. (1979) Apolipoprotein A-II and structure of human serum high density lipoproteins. An approach by reassembly techniques. J. Biol. Chem. 254, 2517-2525
49. Durbin, D. M., and Jonas, A. (1999) Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase. J. Lipid Res. 40, 2293-2302
50. Clay, M. A., Pyle, D. H., Rye, K. A., and Barter, P. J. (2000) Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. J. Biol. Chem. 275, 9019-9025
51. Edelstein, C., Lim, C. T., and Scanu, A. M. (1972) On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction III). J. Biol. Chem. 247, 5842-5849
52. Scanu, A. M., Lim, C. T., and Edelstein, C. (1972) On the subunit structure of the protein of human serum high density lipoprotein. II. A study of Sephadex fraction IV. J. Biol. Chem. 247, 5850-5855
53. Rye, K. A., Wee, K., Curtiss, L. K., Bonnet, D. J., and Barter, P. J. (2003) Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation. J. Biol. Chem. 278, 22530-22536
54. Moore, R. E., Kawashiri, M. A., Kitajima, K., Secreto, A., Millar, J. S., Pratico, D., and Rader, D. J. (2003) Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler. Thromb. Vasc. Biol. 23, 1914-1920
55. Benoit, P. P., Emmanuel, F. P., Caillaud, J. M. M. D., Bassinet, L., Castro, G. P., Gallix, P. D. V. M., Fruchart, J. C. P., Branellec, D. P., Denefle, P. P., and Duverger, N. P. (1999) Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models. Circulation 99, 105-110
56. Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., Halpern, S., Crowe, T., Blankenship, J. C., and Kerensky, R. (2003) Effect of recombinant apoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290, 2292-2300
57. Anantharamaiah, G. M., Mishra, V. K., Garber, D. W., Datta, G., Handattu, S. P., Palgunachari, M. N., Chaddha, M., Navab, M., Reddy, S. T., Segrest, J. P., and Fogelman, A. M. (2007) Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J. Lipid Res. 48, 1915-1923
58. Fukushima, D., Kupferberg, J. P., Yokoyama, S., Kroon, D. J., Kaiser, E. T., and Kezdy, F. J. (1979) A synthetic amphiphilic helical docosapeptide with the surface properties of plasma apolipoprotein A-I. J. Am. Chem. Soc. 101, 3703-3704
59. Yokoyama, S., Fukushima, D., Kupferberg, J. P., Kezdy, F. J., and Kaiser, E. T. (1980) The mechanism of activation of lecithin: cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide. J. Biol. Chem. 255, 7333-7339
60. Bloedon, L. T., Dunbar, R., Duffy, D., Pinell-Salles, P., Norris, R., DeGroot, B. J., Movva, R., Navab, M., Fogelman, A. M., and Rader, D. J. (2008) Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J. Lipid Res. 49, 1344-1352
61. Navab, M., Anantharamaiah, G. M., Reddy, S. T., and Fogelman, A. M. (2006) Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat. Clin. Pract. 3, 540 -547
62. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., and Fogelman, A. M. (2004) Oral D-4F causes formation of pre-{beta} high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109, 3215-3220
63. Blanco-Vaca, F., Escola-Gil, J. C., Martin-Campos, J. M., and Julve, J. (2001) Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 42, 1727-1739
64. Weng, W., and Breslow, J. L. (1996) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. 93, 14788-14794
65. Castellani, L. W., Goto, A. M., and Lusis, A. J. (2001) Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 50, 643-651
66. Castellani, L. W., Nguyen, C. N., Charugundla, S., Weinstein, M. M., Doan, C. X., Blaner, W. S., Wongsiriroj, N., and Lusis, A. J. (2008) Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance. J. Biol. Chem. 283, 11633-11644
67. Gong, E. L., Stoltzfus, L. J., Brion, C. M., Murugesh, D., and Rubin, E. M. (1996) Contrasting in vivo effects of murine and human apolipoprotein A-II. J. Biol. Chem. 271, 5984-5987
68. Van 't Hooft, F. M. M. D. P., Ruotolo, G. M. D. P., Boquist, S. M. D. P., de Faire, U. M. D. P., Eggertsen, G. M. D. P., and Hamsten, A. M. D. P. (2001) Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104, 1223-1228
69. Corella, D., Arnett, D. K., Tsai, M. Y., Kabagambe, E. K., Peacock, J. M., Hixson, J. E., Straka, R. J., Province, M., Lai, C.-Q., Parnell, L. D., Borecki, I., and Ordovas, J. M. (2007) The -256t>c polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin. Chem. 53, 1144-1152
70. Reilly, M. P., and Tall, A. R. (2007) HDL proteomics: pot of gold or Pandora's box? J. Clin. Invest. 117, 595-598
71. Hortin, G. L., Shen, R.-F., Martin, B. M., and Remaley, A. T. (2006) Diverse range of small peptides associated with high-density lipoprotein. Biochem. Biophys. Res. Commun. 340, 909-915
72. 2O/ sucrose or in KBr. J. Lipid Res. 49, 481-490
73. Dawson, G., Kruski, A. W., and Scanu, A. M. (1976) Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J. Lipid Res. 17, 125-131
74. Hara, A., and Taketomi, T. (1987) Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J. Biochem. 102, 83-92
75. Kimura, T., Sato, K., Malchinkhuu, E., Tomura, H., Tamama, K., Kuwabara, A., Murakami, M., and Okajima, F. (2003) High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. [miscellaneous article] Arterioscler. Thromb. Vasc. Biol. 23, 1283-1288
76. Porn, M. I., Akerman, K. E., and Slotte, J. P. (1991) High-density lipoproteins induce a rapid and transient release of Ca2+ in cultured fibroblasts. Biochem. J. 279, 29-33
77. Yuan, Y., Jackson, S. P., Newnham, H. H., Mitchell, C. A., and Salem, H. H. (1995) An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2. Blood 86, 4166-4174
78. Zhang, B., Tomura, H., Kuwabara, A., Kimura, T., Miura, S. I., Noda, K., Okajima, F., and Saku, K. (2005) Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis 178, 199-205
79. Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y., and Kume, S. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121, 969-973
80. Yang, L., Yatomi, Y., Miura, Y., Satoh, K., and Ozaki, Y. (1999) Metabolism and functional effects of sphingolipids in blood cells. Br. J. Haematol. 107, 282-293
81. Yatomi, Y., Ozaki, Y., Ohmori, T., and Igarashi, Y. (2001) Sphingosine 1-phosphate: synthesis and release. Prostagland. Other Lipid. Mediat. 64, 107-122
82. Yatomi, Y., Ruan, F., Hakomori, S., and Igarashi, Y. (1995) Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86, 193-202
83. Hanel, P., Andreani, P., and Graler, M. H. (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21, 1202-1209
84. Ito, K., Anada, Y., Tani, M., Ikeda, M., Sano, T., Kihara, A., and Igarashi, Y. (2007) Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem. Biophys. Res. Commun. 357, 212-217
85. Pappu, R., Schwab, S. K., Cornelissen, I., Pereira, J. O. P., Regard, J. B., Ying, X., Camerer, E., Yao-Wu, Z., Yong, H., Cyster, J. G., and Coughlin, S. R. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316, 295-298
86. Argraves, K. M., and Argraves, W. S. (2007) HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J. Lipid Res. 48, 2325-2333
87. Deigner, H.-P. A., and Hermetter, A. B. (2008) Oxidized phospholipids: emerging lipid mediators in pathophysiology. Curr. Opin. Lipidol. 19, 289-294
88. Gharavi, N. M., Gargalovic, P. S., Chang, I., Araujo, J. A., Clark, M. J., Szeto, W. L., Watson, A. D., Lusis, A. J., and Berliner, J. A. (2007) High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. [miscellaneous article] Arterioscler. Thromb. Vasc. Biol. 27, 1346-1353
89. Shao, B., Heinecke, J. W., Enrique, C., and Lester, P. (2008) Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high density lipoprotein oxidized by myeloperoxidase. Methods Enzymol. 440, 33-63
90. Zheng, L., Settle, M., Brubaker, G., Schmitt, D., Hazen, S. L., Smith, J. D., and Kinter, M. (2005) Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in abca1-dependent cholesterol efflux from macrophages. J. Biol. Chem. 280, 38-47
91. Jayaraman, S., Gantz, D. L., and Gursky, O. (2008) Effects of protein oxidation on the structure and stability of model discoidal high-density lipoproteins. Biochemistry 47, 3875-3882
92. Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., Geary, R. L., Oram, J. F., and Heinecke, J. W. (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs abca1-dependent cholesterol transport. Proc. Natl. Acad. Sci. 101, 13032-13037
93. Zheng, L., Nukuna, B., Brennan, M.-L., Mingjiang, S., Goormastic, M., Settle, M., Schmitt, D., Xiaoming, F., Thomson, L., Fox, P. L., Ischiropoulos, H., Smith, J. D., Kinter, M., and Hazen, S. L. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114, 529-541
94. Hoang, A., Murphy, A., Coughlan, M., Thomas, M., Forbes, J., O'Brien, R., Cooper, M., Chin-Dusting, J., and Sviridov, D. (2007) Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia 50, 1770-1779
95. Anantharamaiah, G. M., Hughes, T. A., Iqbal, M., Gawish, A., Neame, P. J., Medley, M. F., and Segrest, J. P. (1988) Effect of oxidation on the properties of apolipoproteins A-I and A-II. J. Lipid Res. 29, 309-318
96. Gursky, O., and Atkinson, D. (1996) Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc. Natl. Acad. Sci. 93, 2991-2995
97. Panagotopulos, S. E., Horace, E. M., Maiorano, J. N., and Davidson, W. S. (2001) Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. J. Biol. Chem. 276, 42965-42970
98. Rye, K. A., Hime, N. J., and Barter, P. (1997) Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J. Biol. Chem. 272, 3953-3960
99. Rye, K. A., and Barter, P. J. (1994) The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J. Biol. Chem. 269, 10298-10303